Lyphe Australia Brand Profile
Lyphe Group is a patient-centred medicinal cannabis access company, dedicated to bringing medical cannabis treatments to patients with unmet clinical needs.
At Lyphe Group we believe all patients with unmet clinical needs should be able to access medicinal cannabis. Lead by the experts, guided by science and dedicated to improving people’s lives, The Lyphe Group is trusted by regulators, Governments, the public and our partners to open up access to medical cannabis for patients across the world.
Lyphe Australia Product List
Swipe left on table to view more detail.
| Form | Product Name | Size | THC | CBD | # of Reviews | Rating | Price |
|---|---|---|---|---|---|---|---|
| Aelleve Balance10 | 30ml | 10mg/ml | 10mg/ml | 0 | Sign In | Sign In | |
| Aelleve Balance25 | 30ml | 25mg/ml | 25mg/ml | 0 | Sign In | Sign In | |
| Aelleve T26 | 30ml | 26mg/ml | <1mg/ml | 0 | Sign In | Sign In | |
| Aelleve CBD100+ | 30ml | 0mg/ml | 100mg/ml | 0 | Sign In | Sign In | |
| Aelleve WF THC20 LL | 10g | 20% | <1% | 2 | Sign In | Sign In | |
| Aelleve WF THC24 GTH | 10g | 24% | <1% | 2 | Sign In | Sign In | |
| Aelleve Day Live Rosin Cart | 0.5g | 350mg | <0.1mg | 0 | Sign In | Sign In | |
| Aelleve Night Live Rosin Cart | 0.5g | 350mg | <0.1mg | 0 | Sign In | Sign In | |
| Aelleve WF THC24 MK | 10g | 24% | <1% | 0 | Sign In | Sign In | |
| Aelleve Access 22 Indica | 10g | 22% | <1% | 1 | Sign In | Sign In | |
| Aelleve Access 22 Sativa | 10g | 22% | <1% | 0 | Sign In | Sign In |
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. CANNABIS IS A SCHEDULED AND REGULATED DRUG.
The information above is not to be taken as medical advice. Cannabis may have negative side effects or interactions with other medications. Medical Cannabis is not effective for everyone and more research needs to be done. Please consult a health professional for advice. Canna Reviews does not receive financial incentives or compensation for displaying product information.